Ethyl 2-(dihydro-2H-pyran-4(3H)-ylidene)acetate, 95.0%, 5g

1-(Trifluoromethyl)cyclopropane-1-carboxylic Acid>98.0%(GC)(T)1g

2,3,5,6-Tetramethylpyrazine, 95.0%, 10g

Ácido malónico, mínimo 99 %, para síntesis, 1 kg, envase de vidrio

2,2-Dimethyl-1,2,3,4-tetrahydroquinoline, 95%, 250mg

4,4,5,5-Tetramethyl-2-(phenylethynyl)-1,3,2-dioxaborolane, 95.0%, 1g

4-Hydrazinylbenzoic acid hydrochloride, 95.0%, 25g

N-(3-Hydroxyphenyl)-4-methylbenzene-1-sulfonamide, 97%, 100mg

N-Boc-4-(4-Toluenesulfonyloxymethyl)piperidine, 96.0%, 25g

5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-2-(trifluoromethyl)benzonitrile, 96%, 5g

(2S,4R)-1-Boc-4-amino-L-proline methyl ester hydrochloride, 97.0%, 5g

1-Boc-4-Methylpiperidine, 97.0%, 25g

9,9'-Bianthracene, 95.0%, 10g